clopidogrel

Original Contribution

Toward Personalized DAPT: Is There an Inter-Manufacturer Difference in Generic Clopidogrel Response?

11/23/2022

Yuhe Xia , MS;

Hamza Ahmed , BS;

Daniela Iskhakov , PA-C;

Frederick Feit , MD;

Carlos L. Alviar , MD;

Norma Keller , MD;

Sripal Bangalore , MD, MHA;

Jeffrey S. Berger , MD, MS;

Sylvie Hall , PharmD, MPH;

This quality-improvement project included 515 adult patients receiving clopidogrel for ACS or ischemic heart disease and referred for coronary angiography/percutaneous coronary intervention. The project was divided into 2 phases: (1)...

This quality-improvement project...

11/23/2022

Journal of Invasive Cardiology

Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry

07/14/2019

Sorin J. Brener , MD;

Terrence J. Sacchi , MD;

Venkatesh Alapati , MD;

Max M. Benson , MD;

Doris Chan , DO;

Gregory J. Cunn , MD;

Saadat Khan , MD;

Issa Kutkut , MD;

John P. O'Laughlin , MD;

Chockalingham Arun Narayanan , MD;

We identified ACS patients from our institutional registry who underwent PCI and received either ticagrelor or clopidogrel and compared 1-year all-cause death rates.

We identified ACS patients from...

07/14/2019

Journal of Invasive Cardiology

Original Contribution

Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients

07/15/2018

Pierre Robert , MD;

Patrick Messner-Pellenc , MD, PhD;

Florence Leclercq , MD, PhD;

Guillaume Cayla , MD, PhD;

Benoit Lattuca , MD;

David Belardi , MD;

Christophe Demattei , MD;

Laurent Schmutz , MD;

Luc Cornillet , MD;

Bertrand Ledermann , MD;

Jean-Christophe Macia , MD;

A. Lemmi , MD;

Richard Gervasoni , MD;

Francois Roubille , MD, PhD;

Thien Tri Cung , MD;

Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before PCI in elective and NSTEMI patients. This study assesses outcomes after performing PCI immediately after coronary angiography with an exclusive...

Recent studies have challenged...

07/15/2018

Journal of Invasive Cardiology

Letters to the Editor

Prehospital Clopidogrel Administration in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary PCI: Real-Life Experience From the Multicenter NRDES Registry

05/27/2016

Tomasz Rakowski , MD, PhD;

Zbigniew Siudak , MD, PhD;

Dariusz Dudek , MD, PhD, FESC;

Agata Sawina , MD;

Artur Dziewierz , MD, PhD;

We sought to compare outcomes of STEMI patients from the National Registry of Drug-Eluting Stents (NRDES) stratified by time of clopidogrel loading dose administration.

We sought to compare outcomes of...

05/27/2016

Journal of Invasive Cardiology

Delayed Clopidogrel Transit During Myocardial Infarction Evident on Angiography

04/29/2015

C. Michael Gibson , MS, MD;

Duane S. Pinto , MD, MPH;

Joanna Ghobrial , MD, MS;

We describe the case of a patient with NSTEMI where oral clopidogrel loading prior to PCI was directly visualized on angiography, implying a very low likelihood of adequate absorption or antiplatelet effect. This observation raises the...

We describe the case of a...

04/29/2015

Journal of Invasive Cardiology